Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial was for people whose general health and activity wasn’t very good because of their cancer.
Doctors measure your general health and activity using an internationally recognised scale called performance status. This trial is for people with a performance status of 2.
This trial was open for people to join between November 2016 and December 2017 and allowed 2 years for treatment and patient follow up. The team published the results in March 2020.
Recruitment start: 7 November 2016
Recruitment end: 31 December 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gary Middleton
University of Birmingham
Merck Sharp & Dohme Ltd
Cancer Research UK Clinical Trials Unit
Last reviewed: 20 January 2021
CRUK internal database number: 14452
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
